Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Knight Therapeutics Inc.
DescriptionSelective nNOS and iNOS inhibitor
Molecular Target Neuronal nitric oxide synthase 1 (NOS1) (nNOS) ; Inducible nitric oxide synthase 2 (NOS2) (iNOS)
Mechanism of ActionNitric oxide (NO) synthase inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationPain
Indication DetailsTreat inflammatory pain
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today